← Spire Therapeutics

What podcasts say about Spire Therapeutics

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Spire Therapeutics

1 statement · 1 negative

  1. Katie GreifeldNegativeAug 25, 2026· Stock Movers

    Spire Therapeutics’ drug missed its internal monotherapy-development threshold.

    “the drug kind of fell short of the company's internal bar for developing it as a monotherapy.”

    Listen at 2:01

    Open the episode · Intuit Slumps, Spyre Therapeutics Mixed, Dick's Sporting Goods Slides

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.